Business · 16/03/2020Updated: 10/17/2026 · 1 min read
FDA Extends Comment Period for Homeopathic Drug Guidance
Summary
The Food and Drug Administration (FDA) is extending the comment period for its draft guidance on homeopathic drugs, allowing more time for industry and staff to submit comments, following the notice published in the Federal Register on October 25, 2019.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →